论文部分内容阅读
目的:观察乳酸左氧氟沙星联合替硝唑治疗妇科盆腔炎的临床疗效。方法:选取我院收治的妇科盆腔炎患者200例,将其随机分为对照组与试验组,每组各100例,前者静滴氧氟沙星联合甲硝唑治疗,后者静滴乳酸左氧氟沙星联合替硝唑治疗,比较临床疗效。结果:治疗前,两组的CRP含量无显著差异,P>0.05;治疗后,试验组的CRP含量下降,且远低于对照组,P<0.05;对照组治疗的总有效率为73.0%,痊愈率为23.0%,低于试验组(总有效率为83.0%,痊愈率为61.0%),P<0.05;试验组的不良反应发生率为5%,低于对照组(21.0%),P<0.05。结论:在妇科盆腔炎的治疗中,应用乳酸左氧氟沙星联合替硝唑能够缓解临床症状,改善体征,且不良反应少,有较高的安全性。
Objective: To observe the clinical efficacy of levofloxacin lactate combined with tinidazole in the treatment of gynecologic pelvic inflammatory disease. Methods: 200 cases of gynecologic pelvic inflammatory disease admitted to our hospital were selected and randomly divided into control group and test group, 100 cases in each group. The former was treated with ofloxacin combined with metronidazole, the latter with intravenous infusion of levofloxacin lactate Combined tinidazole treatment, more clinical efficacy. Results: Before treatment, there was no significant difference in CRP content between the two groups (P> 0.05). After treatment, the CRP level in the experimental group decreased and was significantly lower than that in the control group (P <0.05). The total effective rate in the control group was 73.0% The cure rate was 23.0%, lower than the experimental group (total effective rate was 83.0%, the cure rate was 61.0%), P <0.05; adverse reactions in the experimental group was 5%, lower than the control group (21.0%), P <0.05. Conclusion: In the treatment of pelvic inflammatory disease, the application of levofloxacin combined with tinidazole can relieve the clinical symptoms and improve the signs, with less adverse reactions and higher safety.